Recombinant Human PILRA Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00163P-100UG
Human PILRA on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human PILRA Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00163P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
| Description | Recombinant Human PILRA Protein is expressed from HEK293 with His tag at the C-terminus.It contains Gln20-Ala197. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Accession | Q9UKJ1 |
| Target Symbol | PILRA |
| Species | Human |
| Expression System | HEK293 |
| Tag | C-His |
| Expression Range | Gln20-Ala197 |
| Mol. Weight | The protein has a predicted MW of 21.32 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Endotoxin | Less than 1EU per ug by the LAL method. |
| Activity | Immobilized Human PILRA, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-PILRA Antibody, Rabbit IgG Tag with the EC50 of 8.9ng/ml determined by ELISA. Contact us for detailed testing images. |
| Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | Shipped at ambient temperature. |
| Gene Background | Alzheimer's disease (AD) is a neurodegenerative disease characterized by a progressive decline in cognitive performance; Mild Cognitive Impairment (MCI) is instead an objective decline in cognitive performance that does not reach pathology. Paired immunoglobulin-like type 2 receptor alpha (PILRA) is a cell surface inhibitory receptor that was recently suggested to be involved in AD pathogenesis. In particular, the arginine-to-glycine substitution in position 78 (R78, rs1859788) was shown to be protective against AD. |
